Norditropin Flexpro (Somatropin)

Somatropin, the active ingredient in Norditropin Flexpro, is a recombinant human growth hormone presented as a solution for injection (pre‑filled pen) for subcutaneous use. It treats growth hormone deficiency and related growth disorders in children and adults, supporting normal growth, metabolism and body composition.

GNH USA supplies Norditropin Flexpro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides cold‑chain logistics for biologic products. This ensures product integrity from manufacture to delivery.

Norditropin Flexpro (somatropin) is used in growth hormone therapy to address conditions characterized by insufficient endogenous growth hormone.

- Growth hormone deficiency: promotes linear growth in children and improves body composition in adults. - Turner syndrome: supports height increase during puberty. - Chronic renal insufficiency: helps improve growth velocity in pediatric patients. - Prader‑Willi syndrome: assists in achieving normal growth patterns. - Noonan syndrome (short stature associated): enhances growth rate. - Idiopathic short stature: facilitates increased height gain.

Somatropin may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Injection site pain or erythema. - Headache. - Joint or muscle aches. - Peripheral edema. - Nausea. - Fatigue.

Serious or Rare Side Effects: - Intracranial hypertension. - Slipped capital femoral epiphysis. - Hyperglycemia or new‑onset diabetes. - Allergic reactions including anaphylaxis. - Tumor recurrence or progression. - Cardiomyopathy.

When prescribing Norditropin Flexpro, clinicians should consider several safety measures.

- Dose titration: adjust based on IGF‑1 levels and growth response. - Monitoring: regular assessment of glucose, thyroid function and ophthalmologic status. - Contraindications: avoid in patients with active malignancy. - Pregnancy and lactation: use only if potential benefit outweighs unknown risk. - Storage: Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze or shake.

Somatropin can interact with other medications, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Glucocorticoids: may antagonize growth‑promoting effects. - Oral estrogen therapy: can diminish IGF‑1 response. - High‑dose insulin: may increase risk of hypoglycemia.

Moderate Interactions (Monitor Closely): - Thyroid hormone replacement: may need dose adjustment. - Diabetes medications: monitor blood glucose closely. - Antidiabetic sulfonylureas: potential enhanced hypoglycemia. - Anticonvulsants (e.g., phenobarbital): may alter somatropin metabolism.